IL-1 signaling has been increasingly implicated in chemoresistance in multiple solid tumors, including breast, gastric, non-small cell lung cancer, head and neck squamous cell carcinoma, and colorectal cancer [33,34,35,36,37,38]. Here, IL1B is linked to head and neck squamous cell carcinoma.